Table 1.

Adverse effects of mesalamine and thiopurines in a cohort of IBD patients[18]

Event	Number	Percentage (%)
Mesalamine (n = 44)
Pulmonary dysfunction	3	6.8
Pancreatitis	1	2.2
Hemolytic anemia	1	2.2
Intolerance to local drug vehicle	1	2.2
Platelet reduction	1	2.2
Diarrhea	1	2.2
Total	8	17.8
Thiopurines (n = 57)
Leukopenia	10	17.5
Hepatic damage	5	8.77
Infection	4	7.0
Pancreatitis	4	7.0
Idiosyncracy	2	3.50
Nausea	1	1.75
Malignancy	1	1.75
Total	27	47